Trials / Withdrawn
WithdrawnNCT00785902
AtriCure Bipolar Radiofrequency Ablation of Persistent Atrial Fibrillation
- Status
- Withdrawn
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- AtriCure, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
ABLATE Persistent is a prospective, non-randomized multi-center clinical trial to demonstrate the safety and effectiveness of the AtriCure Bipolar System for treating persistent atrial fibrillation during concomitant on-pump cardiac surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AtriCure Bipolar System |
Timeline
- First posted
- 2008-11-05
- Last updated
- 2011-02-21
Source: ClinicalTrials.gov record NCT00785902. Inclusion in this directory is not an endorsement.